News Article and Medical Journal

The following article contains informations about 2009-10 Seasonal Influenza Vaccine regarding its types and dosages.  All influenza vaccines available in the United States for the 2009-10 influenza season are produced using embryonated hen’s eggs and contain residual egg protein and also contain no adjuvants, according to the CDC MMWR weekly report.

The age groups, precautions, and contraindications approved for the influenza A (H1N1) 2009 monovalent vaccine are identical to those approved for seasonal vaccines. Influenza A (H1N1) 2009 monovalent vaccine approvals vaccines were made on the basis of standards developed for vaccine strain changes for seasonal influenza vaccines, …

As also stated by the FDA, there are CSL Limited, MedImmune LLC, Novartis Vaccines and Diagnostics Limited, and Sanofi Pasteur Inc which received approval for the influenza vaccine manufacturers. The H1N1 vaccines approved today undergo the same rigorous FDA manufacturing oversight, product quality testing and lot release procedures that apply to seasonal influenza vaccines, said the acting chief scientist of the FDA.

Influenza Article: 2009-10 Seasonal Influenza Vaccine Type, Age Group and Dosage continued »

The following article is a clinical practice guideline that consist of informations about the Management of Sickle Cell Disease in Children. This hematology article guideline is not intended to replace long-term management by a paediatric hematologist, but are focussed at management of children with complications of sickle cell disease.

What you will find in this Sickle Cell Disease Article are sections such as Inclusion Criteria of Paediatric patient presenting to ER, General Recommendations for the Management of Paediatric Sickle Cell Disease, Guidelines for Specific Clinical Settings (vaso-occlusive crisis/VOC, Fever/Rule Out Infection), Antimicrobial Therapy Guidelines, and Acute Chest Syndrome or Pneumonia Management.

2004 Hematology Article Guideline: Management of Children Sickle Cell Disease Complication continued »

The herein article, guidelines about to support planning an effective allocation of influenza vaccine and consistent responses by states and communities regarding prevention of pandemic influenza. It concomitantly with the goal of influenza vaccination program to vaccinate all persons in the United States who choose to be vaccinated.

What you will see in the depth of the influenza vaccine article are sections discuss about General Principles and Guidance on Pandemic Vaccination, Framework for Targeting Pandemic Influenza Vaccine, Defining vaccination target groups, Guidance for Prioritizing Pandemic Vaccination as defined by PSI, and Plan for Allocation and Distribution of Vaccine to States and Communities.

Article Guideline: Allocation of Influenza Vaccine in the Role of Pandemic Influenza Prevention continued »

Herein is an Anaesthesiology Journal which described Hyperbaric Oxygen Therapy(HBOT) in association with the treatment of severe head trauma. It needs an early treatment in such prehospital phase in order to control its mortality and morbidity since traumatic brain injury has been the primary concern to the health care provider for many years.

In the depth of the article you will find sections discuss about the adequate oxygen therapy in the form of normobaric hyperoxia and hyperbaric oxygen therapy could be a promising therapy in the management of severe head injury based on the guidelines already established.

2006 Journal: Hyperbaric Oxygen Therapy (HBOT) in Severe Head Injury continued »